ErythromycinAcistrate
- CAS No.
- 96128-89-1
- Chemical Name:
- ErythromycinAcistrate
- Synonyms
- ErythromycinAcistrate;[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] acetate
- CBNumber:
- CB51402156
- Molecular Formula:
- C57H105NO16
- Molecular Weight:
- 1060.46
- MDL Number:
- MOL File:
- 96128-89-1.mol
Last updated:2022-12-21 16:56:50
| FDA UNII | 6383U5A1KE |
|---|
ErythromycinAcistrate Chemical Properties,Uses,Production
Description
Erythromycin acistrate is a prodrug of erythromycin with lowered liver toxicity, improved phmacokinetics, and greatly reduced gastro-intestinal side-effects. It is indicated for respiratory tract infections, skin infections and chlamydial urethritis.
Originator
Orion (Finland)
Uses
Antibacterial.
brand name
Erasis (Orion Pharmaceutica, Finland).
ErythromycinAcistrate Preparation Products And Raw materials
Raw materials
Preparation Products
96128-89-1(ErythromycinAcistrate)Related Search:
ErythromycinAcistrate
[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] acetate
96128-89-1
C57H105NO16